Ultime notizie per 8x8 (NASDAQ:EGHT) Azioni

8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.

8x8 Inc

Twilio Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/twlo#NYSE">TWLO</a>) provides developers and businesses tools and products to enhance their communications with customers. Its cloud communication-as-a-service (CPaaS) platform offers basic services like voice, email, and SMS messaging to more advanced interactive services like video, artificial intelligence (AI) chatbots, voice application programming interfaces (APIs), and identity authentication. Gartner ranked it as a CPaaS leader in its Magic Quadrant for the second year in 2024. Twilio has leveraged AI into its services to provide more flexibility and enhance experiences.
The computer and technology sector leader has well-known clients, including the top streaming service Netflix Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nflx#NASDAQ">NFLX</a>), Airbnb Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abnb#NASDAQ">ABNB</a>), and rideshare duopolies Uber Technologies Inc.&nbsp;and Lyft Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>). It competes with 8X8 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eght#NASDAQ">EGHT</a>).
<h2>The Value Proposition of CPaaS </h2>
On the surface, CPaaS may not seem like a big deal, especially as an end user.&nbsp;However, the benefit of CPaaS, like most&nbsp;as-a-service platforms (aaS), is not having to bear the expense of in-house building, managing, maintaining, and upgrading the complex hardware and software infrastructure. This and the ability to scale the services to millions of customers are the major value propositions. Businesses use CPaaS to embed communication channels like voice calls, video, email, and text messaging into their mobile apps. Consumers often take these services for granted because they are commonplace these days.
For example, If you&#39;ve ever ordered an Uber or Lyft ride through their mobile apps, Twilio&#39;s platform enables the rideshare app to:
<ul>
<li>Send an SMS notification when a driver has been found.</li>
<li>Provide real-time location updates notifying you the driver is on the way and has arrived.</li>
<li>Enables driver and passenger communication features like calling and texting if you&#39;re wondering where the driver is.</li>
<li>Enables text, email, and voice calling options to contact customer service if there&#39;s a problem.</li>
</ul>
<h2>Rich Communication Services (RCS) Is a Game Changer</h2>
Twilio offers RCS, enabling businesses to take their text messaging to the next level without users downloading more apps. RCS enables companies to send rich media like videos, images, logos, and pictures in text messages. It can include buttons, links, or other triggers enabling the end user to take an action like making a payment, voting, or booking an appointment. It provides a more interactive and branded communication experience with customers, ultimately leading to an improved customer experience and higher conversion rates.
<h2>Twilio Leverages AI Services Like Auto Pilot and Flex Insights </h2>
Twilio offers its tools and services as APIs that companies and developers can customize to refine their brand and use cases. AI products like Autopilot let developers create, train, and customize interactive voice response (IVR) systems and intelligent AI chatbots that can engage customers, understand natural language, automate tasks, and authenticate and transfer customers to the right agents. Flex Insights monitors and analyzes conversations between customers and agents to provide data analytics, sentiment analysis, and transcription services to optimize workflows for and with agents.
<h2>Twilio&#39;s Recovery Is Taking Shape </h2>
Twilio&#39;s second-quarter of 2024 results indicate that business is recovering. The company reported a 17 cents EPS beat, coming in at 87 cents. Revenues grew 4.4% YoY to $1.08 billion, which also beat consensus estimates of $1.06 billion. They grew their active customer accounts to over 316,000 in the quarter compared to 304,000 in the year-ago period. The company has $800 million left in its $2 billion share buyback program, which it will complete by year&#39;s end.
The company issued Q3 2024 EPS of 81 to 86 cents versus 74 cents consensus estimates. Twilio expected revenues of $1.085 billion to $1.095 billion versus $1.09 billion consensus estimates. For fiscal 2024, Twilio is raising its non-GAAP income from operations, which ranges from $650 million to $670 million, up from the previous forecast of $585 million to $635 million. Organic revenue growth was narrowed to 6% to 7% compared to 5% to 10% previously forecast.
<h2>TWLO Stock Is in an Ascending Triangle Pattern </h2>
An ascending triangle is a bullish pattern comprised of a flat-top upper trendline resistance indicating the supply overhand. The ascending (rising) trendline is formed by higher lows, indicating rising demand. A breakout occurs when the stock surges through the upper trendline, whereas a breakdown occurs if the stock falls below the ascending trendline.
<img alt="Twilio TWLO stock chart" class="aligncenter" src="https://www.marketbeat.com/logos/articles/med_20240922163137_chartq-twlo.jpg" style="height:748px; width:915px" />
TWLO has an upper trendline resistance at $63.91. The stock has been recovering since the $52.51 swing low. The anchored VWAP support is steadily rising at $58.86. As TWLO rises to test the flat-top resistance, it also has the potential to reach the lower gap-fill level at $64.89. The upper gap fill would occur if TWLO rises to $68.85. The daily relative strength index (RSI) is rising to the 61-band. Fibonacci (Fib) pullback support levels are at $61.47, $59.56, $56.86, and $53.81.
Twilio&#39;s average consensus price target is $70.52, and its highest analyst price target is $110.00. &nbsp;
Bullish investors can buy on pullbacks using cash-secured puts at the fib pullback support levels to buy the dip and write covered calls at fib extensions to execute a wheel strategy for income.
By implementing a bullish call debit spread, bullish options investors can limit maximum downside and profit from modest upside gains for less capital than owning the stock.
The article &quot;<a href="https://www.marketbeat.com/originals/seize-the-growth-twilios-ai-innovations-are-driving-huge-upside/">Seize the Growth: Twilio&#39;s AI Innovations Are Driving Huge Upside</a>&quot; first appeared on MarketBeat.

Large Cap

Mid Cap

News

Penny Stocks

Price Target

Technicals

Buybacks

Small Cap

Markets

Analyst Ratings

Tech

Trading Ideas

ABNB

EGHT

LYFT

NFLX

TWLO

Seize the Growth: Twilio's AI Innovations Are Driving Huge Upside

Rosenblatt analyst Catharine Trebnick maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Buy and maintains $4 price target.

Rosenblatt Maintains Buy on 8x8, Maintains $4 Price Target

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to<a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Ouster Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>)</h3>
<ul>
<li>On Aug. 13, Ouster reported worse-than-expected second-quarter sales results and issued third-quarter revenue guidance below estimates. "Our second quarter results showcase solid execution with GAAP gross margin increasing to 34%. Consistent with Ouster's strategy of expanding into software solutions, we had one of our best quarters for software-attached sales powered by Ouster Gemini and Blue City. Alongside the continued improvement in our operating results, we have built one of the industry's most resilient balance sheets and diversified business models," said Ouster CEO Angus Pacala. The company's stock fell around 45% over the past month and has a <a href="https://www.benzinga.com/quote/OUST">52-week low of $3.67</a>.</li>
<li>RSI Value: 28.96</li>
<li>OUST Price Action: Shares of Ouster fell 2% to close at $7.85 on Monday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent082024&amp;t=be2bearmibe3na1"> latest OUST news. </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent082024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="887" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045457/image-161.png" alt="" class="wp-image-503020" style="width:631px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045457/image-161.png 887w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045457/image-161-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045457/image-161-768x720.png 768w" sizes="(max-width: 887px) 100vw, 887px" /></a></figure>
<h3 class="wp-block-heading">Smith Micro Software Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMSI#NASDAQ">SMSI</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Aug. 1, Smith Micro Software reported worse-than-expected second-quarter financial results. &#8220;With the commercial launch of Boost Family Guard during the second quarter, our continued progress towards the upcoming launch of a SafePath&#xAE;-based Family Safety solution with a tier one carrier in Europe, and our cost reduction initiatives, we believe we are making progress toward a return to growth, profitability and free cash flow,&#8221; said William W. Smith Jr., president, chief executive officer, and chairman of the board of Smith Micro. The company's stock fell around 64% over the past month. It <a href="https://www.benzinga.com/quote/SMSI">has a 52-week low</a> of $0.77.</li>
<li>RSI Value: 19.79</li>
<li>SMSI Price Action: Shares of Smith Micro Software fell 3.2% to close at $0.81 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent082024&amp;t=be2bearmibe3na1">trend in SMSI stock. </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent082024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="917" height="840" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045555/image-162.png" alt="" class="wp-image-503026" style="width:703px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045555/image-162.png 917w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045555/image-162-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045555/image-162-768x704.png 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
<h3 class="wp-block-heading">8&#215;8 Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>)</h3>
<ul>
<li>On Aug. 7, 8&#215;8 reported worse-than-expected first-quarter financial results. Additionally, the company cut its FY25 revenue guidance and issued second-quarter revenue guidance below estimates. The company's shares fell around 44% over the past month and has a 52-week<a href="https://www.benzinga.com/quote/EGHT"> low of $1.52.</a></li>
<li>RSI Value: 29.48</li>
<li>EGHT Price Action: Shares of 8&#215;8 rose 2.4% to close at $1.73 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent082024&amp;t=be2bearmibe3na1">breakout in EGHT shares. </a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent082024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="877" height="825" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045735/image-163.png" alt="" class="wp-image-503030" style="width:560px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045735/image-163.png 877w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045735/image-163-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/20045735/image-163-768x722.png 768w" sizes="(max-width: 877px) 100vw, 877px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40454461/s-p-500-nasdaq-extend-gains-for-8th-consecutive-session-investor-sentiment-improves-but-greed-index">S&amp;P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>

Long Ideas

Pre-Market Outlook

OUST

SMSI

Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter

Throughout the last three months, 6 analysts have evaluated 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>), offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $2.67, a high estimate of $4.00, and a low estimate of $1.50. Highlighting a 15.77% decrease, the current average has fallen from the previous average price target of $3.17. 
<img src="https://www.benzinga.com/files/images/story/2024/1723208507_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The analysis of recent analyst actions sheds light on the perception of 8x8 by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Macwilliams</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$2.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$3.00</td>
<td>$3.50</td>
</tr>
<tr>
<td>Catharine Trebnick</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$4.00</td>
<td>$4.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$1.50</td>
<td>$2.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$2.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$3.50</td>
<td>$3.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to 8x8. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of 8x8 compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for 8x8's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of 8x8's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EGHT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on 8x8 analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know 8x8 Better</h2>
8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.
<h3>Financial Milestones: 8x8's Journey</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Decline in Revenue: Over the 3 months period, 8x8 faced challenges, resulting in a decline of approximately -0.71% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: 8x8's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -5.78%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -9.96%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): 8x8's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -1.36%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: 8x8's debt-to-equity ratio stands notably higher than the industry average, reaching 4.57. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Critical Insights From 8x8 Analyst Ratings: What You Need To Know

Barclays analyst Ryan Macwilliams maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Equal-Weight and lowers the price target from $3 to $2.

Barclays Maintains Equal-Weight on 8x8, Lowers Price Target to $2

Needham analyst Ryan Koontz maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Buy and lowers the price target from $3.5 to $3.

Needham Maintains Buy on 8x8, Lowers Price Target to $3

WIIM

8x8 shares are trading lower after the company reported worse-than-expected Q1 financial results. Additionally, the company cut its FY25 revenue guidance and issued Q2 revenue guidance below estimates.

Fiscal Year 2025 Ending March 31, 2025
<ul>
<li>Service revenue in the range of&nbsp;$685 million&nbsp;to&nbsp;$707 million.</li>
<li>Non-GAAP operating margin in the range of&nbsp;10%&nbsp;to&nbsp;11%.</li>
</ul>

Guidance

8x8 Cuts FY25 Total Revenue Forecast From $720M - $738M To $710M - $732M, Est $728.20M

Second Quarter&nbsp;Fiscal 2025 Ending September 30, 2024
<ul>
<li>Service revenue in the range of&nbsp;$170 million&nbsp;to&nbsp;$174 million.</li>
<li>Non-GAAP operating margin in the range of approximately&nbsp;10%&nbsp;to&nbsp;11%.</li>
</ul>

8x8 Expects Q2 Total Revenue Of $175M - $181M, Est $181.21M

8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.09 by 11.11 percent. This is a 38.46 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $178.147 million which missed the analyst consensus estimate of $178.875 million by 0.41 percent. This is a 2.80 percent decrease over sales of $183.287 million the same period last year.

Earnings

Earnings Misses

8x8 Q1 2025 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $178.147M Miss $178.875M Estimate

NICE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nice#NASDAQ">NICE</a>) shares have gained 9% in the past month, outperforming the Zacks Internet Software industry&#39;s decline of 0.1%.
The upside can be attributed to NICE&#39;s strong growth prospect. It boasts an innovative portfolio with growing adoption of solutions like Actimize, Evidencentral, Inform Elite and CXone. The company&#39;s focus on its cloud offerings, particularly its CXone platform, has been a major growth driver.
In the first quarter of 2024, NICE reported cloud revenues of $468.4 million, up 27% year over year. It witnessed a remarkable 200% year-over-year increase in AI deals in first-quarter 2024, highlighting the increasing demand for AI-driven CX solutions.
NICE&#39;s efforts to enhance its customer base on the back of its robust cloud solutions is a key catalyst. It has more than 25K customers with more than 85% of Fortune 100 customers.
For 2024, cloud revenues are expected to grow roughly 18% or more. NICE&#39;s continuous investments in the global expansion of its cloud platform will help its aim of reaching 75% cloud gross margin in the next three to five years, which reflects the benefits of an innovative portfolio.
<h3>Robust Portfolio Boosts NICE&#39;s Prospects</h3>
NICE&#39;s policy of frequently updating its portfolio has been a key catalyst as it helps in fending off competitors from other industry players like Five9 (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fivn#NASDAQ">FIVN</a>), Salesforce and 8X8 (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eght#NASDAQ">EGHT</a>).
<h3>YTD Performance</h3>
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/85/71652.jpg?v=1171355687" />
Image Source: Zacks Investment Research
These competitors have also been extending their offerings in the CX market. Five9 recently announced an enhanced collaboration with Salesforce, integrating AI-powered solutions to improve customer experiences in contact centers. In February, 8x8 launched 8x8 Engage, an AI-powered solution that facilitates cross-organization customer engagement.
NICE launched CXone Mpower, integrating Copilot, Autopilot and Actions into a CX-aware AI platform in June.
NICE Actimize is advancing with its upcoming IFM (Integrated Fraud Management) version 11, integrating AI throughout the fraud management lifecycle to enhance accuracy, agility, and operational efficiency through intelligent orchestration and network analytics powered by GenAI.
It has launched the next generation of Enlighten Copilot designed specifically for supervisors and CX decision-makers powered by purpose-built AI.
A deepening partnership with Microsoft&nbsp;is noteworthy. NTR-X Compliance Recording and Assurance Solution has secured transactable solution status in Microsoft&#39;s Azure Marketplace.
<h3>Strong Liquidity Position</h3>
NICE has expanded its share repurchase program, with its board of directors approving a new $500 million program. It plans to accelerate share buyback under the current $300 million program.
The latest program reflects NICE&#39;s commitment to continuously improve shareholders&#39; returns. Its strong balance sheet makes the capital distribution activity sustainable.
As of Mar 31, 2024, cash and cash equivalents (including short-term investments) were $1.5 billion. In the first quarter of 2024, NICE generated $254.5 million of net cash from operations.
In the trailing 12 months ending Mar 31, 2024, net cash from operations was $621 million, with free cash flow of $537.5 million providing ample liquidity.
<h3>Estimate Revisions Are Positive</h3>
For second-quarter 2024, NICE projects non-GAAP revenues between $657 million and $667 million, indicating 14% year-over-year growth at the midpoint. Non-GAAP earnings are estimated in the $2.53-2.63 per share band, suggesting a 21% year-over-year rise at the midpoint.
The Zacks Consensus Estimate for revenues is pegged at $662.88 million, indicating 14.07% growth year over year. The consensus mark for earnings is pegged at $2.58 per share, up 0.8% over the past 60 days, indicating a 21.13% year-over-year increase.
<h3>Estimate Revision</h3>
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/51/71653.jpg?v=2099800903" />
Image Source: Zacks Investment Research
For 2024, total revenues are expected to grow between 14% and 15% to $2.72-$2.74 billion. NICE expects earnings between $10.53 and $10.73 per share, indicating year-over-year growth in the 20-22% range.
The Zacks Consensus Estimate for revenues is pegged at $2.73 billion, indicating 14.73% growth year over year. The consensus for earnings is pegged at $10.64 per share, up 0.4% over the past 60 days and indicating a 21.05% year-over-year increase.
<h3>Conclusion</h3>
NICE is benefiting from strong momentum across its cloud business, driven by the rising adoption of the CXone platform. Its growth prospect, as indicated by the Growth Style Score of A, is hard to ignore.
The Value Style Score of B also suggests NICE is undervalued at this moment.
However, a challenging macroeconomic environment has been a concern. The shares are trading below the 50-day moving average, indicating a bearish trend.
<h3>NICE Trading Below 50-Day SMA</h3>
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/9d/71654.jpg?v=1264794969" />
Image Source: Zacks Investment Research
NICE currently has a Zacks Rank #3 (Hold), suggesting that it may be wise to wait for a more favorable entry point in the stock. However, investors who already own the stock may expect the company&#39;s growth prospects to be rewarding over the long term.
<a href="https://www.zacks.com/stock/news/2303586/nice-up-9-in-a-month-how-should-investors-play-the-stock?cid=CS-BENZ-FT-analyst_blog|most_popular_stocks-2303586">To read this article on Zacks.com click here.</a>

FIVN

NICE

NICE Up 9% in a Month: How Should Investors Play the Stock?

Shares of The Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) fell sharply during Tuesday's session following <a href="https://www.benzinga.com/quote/SCHW/earnings">second-quarter results.</a>
Charles Schwab said adjusted net income declined 2% Y/Y to $1.465 billion. Adjusted EPS fell 3% Y/Y to 73 cents, beating the consensus of 72 cents, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Charles Schwab shares dipped 7.5% to $69.42 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Yoshitsu Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKLF#NASDAQ">TKLF</a>) jumped 109% to $0.6437 after the company reported a year-over-year increase in FY24 financial results.</li>
<li>Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) shares climbed 95.4% to $2.12 after the company obtained an exclusive global license to develop, manufacture, and commercialize its Alzheimer&#8217;s drug.</li>
<li>Logistic Properties of the Americas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) shares climbed 53.8% to $23.71.</li>
<li>NaaS Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) gained 38% to $3.8503.</li>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) gained 38% to $1.4799.</li>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) shares rose 29.2% to $2.9450 after jumping around 63% on Monday.</li>
<li>Conduit Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) gained 27.3% to $0.3055 after declining over 8% on Monday.</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) surged 24.7% to $7.39 after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance.</li>
<li>KWESST Micro Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KWE#NASDAQ">KWE</a>) gained 22.8% to $0.4160</li>
<li>Zenvia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENV#NASDAQ">ZENV</a>) climbed 22.7% to $1.9634. The company announced that it entered into an agreement with Alliance Global Partners to offer and sell Class A common shares up to $20 million.</li>
<li>Locafy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) rose 21% to $4.4150.</li>
<li>SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>) gained 20% to $1.0150.</li>
<li>Koss Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOSS#NASDAQ">KOSS</a>) rose 19.8% to $10.45.</li>
<li>Alpha Technology Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGL#NASDAQ">ATGL</a>) climbed 19.2% to $3.42.</li>
<li>Meiwu Technology Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) shares rose 16.1% to $1.01 after surging around 15% on Monday.</li>
<li>NetSol Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTWK#NASDAQ">NTWK</a>) climbed 16% to $3.0501 as the company signed a $16 million agreement with a major automaker to revolutionize digital car buying and leasing experience in the United States.</li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) gained 15% to $3.6440. Morgan Stanley analyst Josh Baer upgraded Chegg from Underweight to Equal-Weight and lowered the price target from $6.5 to $3.25.</li>
<li>8&#215;8, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) gained 13.3% to $2.8450. 8&#215;8. secured a $200 million term loan at reduced interest rate.</li>
<li>Fate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATE#NASDAQ">FATE</a>) gained 12.8% to $4.39.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) rose 12.8% to $1.8350. PacBio is expected to hold its quarterly conference call to discuss its second quarter financial results on Wednesday, Aug. 7.</li>
<li>Newegg Commerce, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) gained 11.8% to $1.14.</li>
<li>Harmony Gold Mining Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMY#NYSE">HMY</a>) jumped 11.8% to $10.57</li>
<li>Sana Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) surged 11.7% to $7.11.</li>
<li>ServisFirst Bancshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFBS#NASDAQ">SFBS</a>) climbed 10.8% to $78.60 after the company reported better-than-expected second-quarter financial result. Also, Piper Sandler maintained a Neutral rating on the stock and raised its price target from $63 to $70.</li>
<li>Match Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) rose 7.9% to $34.54 after Starboard Value sent a letter to the company outlining initiatives for improving growth, profitability and capital allocation.</li>
<li>Arvinas, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) gained 7.7% to $32.27.</li>
<li>Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) shares rose 7.3% to $68.92 after B of A Securities upgraded the stock from Neutral to Buy.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Cyngn Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares fell 22.1% to $7.15 after jumping 54% on Monday.</li>
<li>Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) shares declined 21.4% to $1.08. Autonomix shares jumped 130% on Monday after the company entered into an agreement with RF Innovations to license intellectual property for its Apex 6 Radiofrequency Generator.</li>
<li>Zeo Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) fell 18% to $3.23.</li>
<li>Clearmind Medicine Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) fell 16.7% to $1.85. Clearmind Medicine announced the FDA clearance for IND application of MEAI-based CMND-100 oral capsule.</li>
<li>Crown LNG Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) declined 15.8% to $2.65.</li>
<li>Funko, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>) shares fell 13.3% to $8.71.</li>
<li>Shapeways Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPW#NASDAQ">SHPW</a>) fell 13.2% to $0.3010.</li>
<li>Vicinity Motor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEV#NASDAQ">VEV</a>) shares dipped 12.8% to $0.5581 after dipping 10% on Monday.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares fell 8.7% to $37.04. Trump Media &amp; Technology Group shares jumped over 31% on Monday following the attempted assassination of Donald Trump.</li>
<li>Greenpro Capital Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRNQ#NASDAQ">GRNQ</a>) shares fell 8.5% to $1.08. Greenpro Capital shares surged around 35% on Monday after the company announced that its subsidiary, Green-X, secured over $100 million in digital assets.</li>
<li>Grom Social Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROM#NASDAQ">GROM</a>) shares declined 7.8% to $0.3945 after gaining around 10% on Monday.</li>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) fell 7.1% to $67.83 after Loop Capital downgraded the stock from Buy to Hold.</li>
<li>Eos Energy Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) fell 7% to $1.9150.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39792248/jim-cramer-says-if-you-sell-this-chinese-ev-stock-now-some-clown-will-be-real-posit">Jim Cramer Says If You Sell This Chinese EV Stock Now, &#8216;Some Clown&#8217; Will Be &#8216;Real Positive About It,&#8217; Wait Until &#8216;All That Stuff Happens</a><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39792248/jim-cramer-says-if-you-sell-this-chinese-ev-stock-now-some-clown-will-be-real-posit">&#8216;</a></li>
</ul>

Intraday Update

Movers

AEON

AMIX

ANGO

ARVN

ATGL

CGBS

CHGG

CMND

EOSE

FATE

FNKO

GRNQ

GROM

KOSS

LCFY

MTCH

NAAS

NEGG

NTWK

PACB

RDDT

SANA

SCHW

SFBS

SHOP

SHPW

SILO

SPRC

TKLF

VRPX

ZENV

Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

U.S. stocks were mostly higher, with the Dow Jones index gaining around 550 points on Tuesday.
Shares of UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) rose sharply during Tuesday's session following a <a href="https://www.benzinga.com/news/earnings/24/07/39790051/unitedhealth-q2-earnings-revenue-and-eps-beat-lifts-cyberattack-impact-estimate-reaffirms-profit-ou">second-quarter earnings beat.</a>
The company reported adjusted EPS of $6.80, up from $6.14 a year ago, beating the consensus of $6.66, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. UnitedHealth&#8217;s revenues increased nearly $6 billion (+6.4% Y/Y) to $98.86 billion, beating the consensus of $98.34 billion, led by expansion in people served domestically at Optum and UnitedHealthcare.
UnitedHealth Group shares gained 5.7% to $544.96 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Logistic Properties of the Americas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) shares surged 53.8% to $23.71.</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) shares gained 24.7% to $7.39 after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance.</li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) jumped 15% to $3.6440. Morgan Stanley analyst Josh Baer upgraded Chegg from Underweight to Equal-Weight and lowered the price target from $6.5 to $3.25.</li>
<li>8&#215;8, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) rose 13.3% to $2.8450. 8&#215;8. secured a $200 million term loan at reduced interest rate.</li>
<li>Fate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATE#NASDAQ">FATE</a>) climbed 12.8% to $4.39.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) gained 12.8% to $1.8350. PacBio is expected to hold its quarterly conference call to discuss its second quarter financial results on Wednesday, Aug. 7.</li>
<li>Newegg Commerce, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) rose 11.8% to $1.14.</li>
<li>Harmony Gold Mining Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMY#NYSE">HMY</a>) climbed 11.8% to $10.57</li>
<li>ServisFirst Bancshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFBS#NASDAQ">SFBS</a>) gained 10.8% to $78.60 after the company reported better-than-expected second-quarter financial result. Also, Piper Sandler maintained a Neutral rating on the stock and raised its price target from $63 to $70.</li>
<li>Wheels Up Experience Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) rose 10.3% to $3.98.</li>
<li>Janux Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JANX#NASDAQ">JANX</a>) jumped 9.7% to $47.69.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) rose 8.1% to $16.34.</li>
<li>Match Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) gained 7.9% to $34.54 after Starboard Value sent a letter to the company outlining initiatives for improving growth, profitability and capital allocation.</li>
<li>Arvinas, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) shares climbed 7.7% to $32.27.</li>
<li>Dream Finders Homes, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFH#NYSE">DFH</a>) rose 7.5% to $30.29.</li>
<li>Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) shares gained 7.3% to $68.92 after B of A Securities upgraded the stock from Neutral to Buy.</li>
<li>Tempus AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) rose 7% to $39.15. Tempus expanded immuno-oncology portfolio with the launch of AI-enabled, multimodal immune profile algorithmic tests.</li>
<li>Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) gained 6.7% to $6.70. Newell Brands is expected to release its second quarter 2024 earnings results on Friday, July 26.</li>
<li>The Scotts Miracle-Gro Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) rose 5.7% to $65.56.</li>
<li>Bank of America Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) rose 5% to $43.99 following upbeat quarterly results.</li>
<li>American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) gained 4.7% to $11.13.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39790965/top-3-health-care-stocks-that-should-keep-you-up-at-night-this-quarter">Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter</a></li>
</ul>

JANX

NVAX

UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America  And Other Big Stocks Moving Higher On Tuesday

<h3>Gainers</h3>
<ul>
<li>Kopin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) shares increased by 5.4% to $0.97 during Thursday's regular session. The company's market cap stands at $111.7 million. </li>
<li>Minim (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MINM#NASDAQ">MINM</a>) stock moved upwards by 4.93% to $3.4. The market value of their outstanding shares is at $9.5 million. </li>
<li>Upland Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPLD#NASDAQ">UPLD</a>) stock increased by 4.88% to $2.79. The company's market cap stands at $76.9 million. </li>
<li>Inseego (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) shares increased by 4.79% to $12.25. The company's market cap stands at $145.5 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares moved upwards by 4.64% to $0.15. The market value of their outstanding shares is at $4.4 million. </li>
<li>American Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSWA#NASDAQ">AMSWA</a>) shares rose 4.4% to $9.48. The company's market cap stands at $315.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Wetouch Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETH#NASDAQ">WETH</a>) stock declined by 13.1% to $2.78 during Thursday's regular session. The market value of their outstanding shares is at $33.1 million. </li>
<li>TROOPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) shares decreased by 8.3% to $2.71. The market value of their outstanding shares is at $275.3 million. </li>
<li>Banzai International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) stock fell 5.83% to $0.15. The market value of their outstanding shares is at $4.1 million. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) stock decreased by 5.55% to $0.37. The company's market cap stands at $5.4 million. </li>
<li>CLPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPS#NASDAQ">CLPS</a>) stock decreased by 5.48% to $0.85. The market value of their outstanding shares is at $21.7 million. </li>
<li>8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) stock declined by 5.34% to $2.13. The market value of their outstanding shares is at $267.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMSWA

BNZI

CLPS

INSG

KOPN

MINM

SOBR

TROO

UPLD

WETH

12 Information Technology Stocks Moving In Thursday's Intraday Session

Ratings for 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $2.7, along with a high estimate of $3.50 and a low estimate of $1.50. Experiencing a 21.97% decline, the current average is now lower than the previous average price target of $3.46. 
<img src="https://www.benzinga.com/files/images/story/2024/1718985697_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive 8x8. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$1.50</td>
<td>$2.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$2.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$3.50</td>
<td>$3.50</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$3.50</td>
<td>$5.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$3.00</td>
<td>$3.80</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to 8x8. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of 8x8 compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for 8x8's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of 8x8's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EGHT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on 8x8 analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About 8x8</h2>
8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.
<h3>A Deep Dive into 8x8's Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, 8x8 faced challenges, resulting in a decline of approximately -2.77% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: 8x8's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -13.15%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -22.29%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): 8x8's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -2.98%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: 8x8's debt-to-equity ratio is notably higher than the industry average. With a ratio of 4.68, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Latest Analyst Ratings For 8x8

Wells Fargo analyst Michael Turrin maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Underweight and lowers the price target from $2 to $1.5.

Wells Fargo Maintains Underweight on 8x8, Lowers Price Target to $1.5

<h3>Gainers</h3>
<ul>
<li>FOXO Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) stock moved upwards by 30.7% to $0.31 during Friday's regular session. The market value of their outstanding shares is at $3.3 million. </li>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) stock increased by 15.31% to $0.61. The company's market cap stands at $58.4 million. </li>
<li>Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) shares increased by 14.71% to $526.25. The market value of their outstanding shares is at $235.7 billion. As per the news, the Q2 earnings report came out yesterday. </li>
<li>iLearningEngines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) shares moved upwards by 10.78% to $7.75. The market value of their outstanding shares is at $1.0 billion. </li>
<li>Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) shares rose 10.41% to $4.83. The market value of their outstanding shares is at $671.1 million. </li>
<li>Mercurity Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) stock moved upwards by 8.99% to $1.66. The market value of their outstanding shares is at $100.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>QXO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) shares declined by 31.4% to $141.0 during Friday's regular session. The company's market cap stands at $93.6 million. </li>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) shares decreased by 19.2% to $0.72. The market value of their outstanding shares is at $17.1 million. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) stock declined by 19.17% to $0.4. The company's market cap stands at $5.9 million. </li>
<li>8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) shares fell 13.61% to $2.0. The market value of their outstanding shares is at $250.7 million. </li>
<li>Nvni Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) shares fell 12.95% to $1.21. The market value of their outstanding shares is at $34.6 million. </li>
<li>LeddarTech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LDTC#NASDAQ">LDTC</a>) stock decreased by 11.96% to $1.03. The company's market cap stands at $30.3 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADBE

AILE

APLD

CLRO

FOXO

LDTC

NVNI

QMCO

12 Information Technology Stocks Moving In Friday's Intraday Session

8x8 shares are trading lower after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $3 to $2.

Morgan Stanley analyst Meta Marshall downgrades 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) from Equal-Weight to Underweight and lowers the price target from $3 to $2.

Downgrades

Morgan Stanley Downgrades 8x8 to Underweight, Lowers Price Target to $2

Bank of America Securities analyst Michael Funk maintained a Buy rating on 8X8 (EGHT – Research Report) today. The company's shares opened today at...

Bank of America Securities Reaffirms Their Buy Rating on 8X8 (EGHT)

8x8 plunges as Q1 results show 'competitive noise,' Baird says

In a report released today, Ryan Koontz from Needham maintained a Buy rating on 8X8 (EGHT – Research Report), with a price target of $3.00. Ryan Ko...

Koontz Recommends Buy on 8X8, Citing Long-Term Growth Potential Despite Short-Term Challenges

In a report released today, Ryan MacWilliams from Barclays maintained a Hold rating on 8X8 (EGHT – Research Report), with a price target of $2.00. ...

Barclays Reaffirms Their Hold Rating on 8X8 (EGHT)

Analysts fell to the sidelines weighing in on 8X8 (EGHT – Research Report) and Alarm (ALRM – Research Report) with neutral ratings, indicating that...

Analysts Are Neutral on These Technology Stocks: 8X8 (EGHT), Alarm (ALRM)

Analyst William Power of Robert W. Baird maintained a Hold rating on 8X8 (EGHT – Research Report), with a price target of $3.00. William Power has ...

8X8 Analyst Report: Hold Rating Amidst Competitive Pressures and Growth Challenges

Mizuho Securities analyst Siti Panigrahi has maintained their neutral stance on EGHT stock, giving a Hold rating on August 9. Siti Panigrahi has gi...

Comments

8x8

Notizie

Ultime notizie per 8x8 (NASDAQ:EGHT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO